National and Kapodistrian University of Athens
Φαρμακοκινητική της ενδοϋαλοειδικής χορήγησης του Avastin (bevacizumab) σε κονίκλους
Abstract
dc:descriptionThe purpose of this study is to describe with great accuracy the pharmacokinetics of intravitreal injection of Avastin in rabbits. Avastin is a very important drug in Ophthalmology today. The right eye of 20 rabbits was injected intravitreally with 1.25 mg/0.05 ml Avastin. Both eyes of four rabbits each time were enucleated at days 1, 3, 8, 15 and 29. Bevacizumab concentrations were measured in vitreous and aqueous of the right eye. The concentration of anti‐bevacizumab antibodies was also measured in serum using the high sensitivity ELISA. Maximum vitreous (406.25 μg/ml) and aqueous humor (5.83 μg/ml) concentrations of bevacizumab in the right eye were measured at day 1. A concentration of 5.17 μg/ml was maintained in the vitreous 29 days after injection. A concentration of 0.225 μg/ml was maintained in aqueous humor 29 days after injection. Half‐life of bevacizumab in the right vitreous and aqueous were 6.61 and 6.51 days respectively. The concentration of anti‐bevacizumab antibodies in serum is at least 200‐fold lower than the bevacizumab concentration. Therefore, anti‐bevacizumab antibodies cannot have an important effect on bevacizumab concentration because of their low concentration.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Sinapis, Christos
- Σινάπης, Χρήστος
Subjects
dc:subject × 8Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/31704